143 related articles for article (PubMed ID: 30184429)
1. Occupancies in the DNA-Binding Pathways of Intrinsically Disordered Helix-Loop-Helix Leucine-Zipper Proteins.
Vancraenenbroeck R; Hofmann H
J Phys Chem B; 2018 Dec; 122(49):11460-11467. PubMed ID: 30184429
[TBL] [Abstract][Full Text] [Related]
2. The Disordered MAX N-terminus Modulates DNA Binding of the Transcription Factor MYC:MAX.
Schütz S; Bergsdorf C; Goretzki B; Lingel A; Renatus M; Gossert AD; Jahnke W
J Mol Biol; 2022 Nov; 434(22):167833. PubMed ID: 36174765
[TBL] [Abstract][Full Text] [Related]
3. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
4. Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex.
Jean-François N; Frédéric G; Raymund W; Benoit C; Lavigne P
J Mol Biol; 2003 Mar; 326(5):1577-95. PubMed ID: 12595267
[TBL] [Abstract][Full Text] [Related]
5. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control.
Brownlie P; Ceska T; Lamers M; Romier C; Stier G; Teo H; Suck D
Structure; 1997 Apr; 5(4):509-20. PubMed ID: 9115440
[TBL] [Abstract][Full Text] [Related]
8. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
[TBL] [Abstract][Full Text] [Related]
10. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization.
Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM
J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766
[TBL] [Abstract][Full Text] [Related]
11. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
Davis LJ; Halazonetis TD
Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
[TBL] [Abstract][Full Text] [Related]
12. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.
Solomon DL; Amati B; Land H
Nucleic Acids Res; 1993 Nov; 21(23):5372-6. PubMed ID: 8265351
[TBL] [Abstract][Full Text] [Related]
13. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
14. Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc.
Yu C; Niu X; Jin F; Liu Z; Jin C; Lai L
Sci Rep; 2016 Mar; 6():22298. PubMed ID: 26931396
[TBL] [Abstract][Full Text] [Related]
15. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
16. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
Muhle-Goll C; Nilges M; Pastore A
Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944
[TBL] [Abstract][Full Text] [Related]
17. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
18. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
19. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
James L; Eisenman RN
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
Farina A; Faiola F; Martinez E
Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]